← Back to Search

Acceptance-Based Behavior Therapy for HIV/AIDS

N/A
Waitlist Available
Led By Ethan Moitra, Ph.D.
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 52 weeks

Summary

This trial will test a new intervention, ABBT, to see if it can help improve HIV patients' commitment to medical care.

Who is the study for?
This trial is for adults over 18 who have recently been diagnosed with HIV and are starting medical care for it. Participants must speak and read English well enough to follow the study procedures and have access to a telephone. People with cognitive impairments cannot join.
What is being tested?
The trial is testing Acceptance-Based Behavior Therapy (ABBT) against an Enhanced-Treatment-as-Usual (ETAU) control condition, aiming to improve commitment to medical care among new HIV patients. It's a randomized study, meaning participants are randomly assigned to one of the two groups.
What are the potential side effects?
Since ABBT is a form of therapy rather than medication, traditional side effects like those seen with drugs aren't expected. However, discussing sensitive topics during therapy could potentially cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~52 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 52 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Retention in medical care
Virologic suppression
Secondary study objectives
Brief HIV Disclosure and Safer Sex Self-Efficacy Scales (BHD)
HIV Stigma Scale (HSS)
Self-Rating Scale Item (SRSI) - Antiretroviral Treatment adherence
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Acceptance-Based Behavior Therapy (ABBT)Experimental Treatment1 Intervention
The 2-session ABBT will be delivered in person at session 1 and by telephone at session 2.
Group II: Enhanced-Treatment-as-Usual (ETAU)Placebo Group1 Intervention
In addition to receiving treatment-as-usual at the clinic, ETAU participants will receive a 2-session program of HIV education.

Find a Location

Who is running the clinical trial?

Brown UniversityLead Sponsor
466 Previous Clinical Trials
698,949 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,928 Previous Clinical Trials
2,744,737 Total Patients Enrolled
Ethan Moitra, Ph.D.Principal InvestigatorBrown University
2 Previous Clinical Trials
250 Total Patients Enrolled

Media Library

Acceptance-Based Behavior Therapy (ABBT) Clinical Trial Eligibility Overview. Trial Name: NCT04201288 — N/A
HIV/AIDS Research Study Groups: Acceptance-Based Behavior Therapy (ABBT), Enhanced-Treatment-as-Usual (ETAU)
HIV/AIDS Clinical Trial 2023: Acceptance-Based Behavior Therapy (ABBT) Highlights & Side Effects. Trial Name: NCT04201288 — N/A
Acceptance-Based Behavior Therapy (ABBT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04201288 — N/A
~1 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top